| Nome |
# |
|
Tocilizumab in MOG-antibody spectrum disorder: a case report, file e268c4cb-5d87-a6b7-e053-3a05fe0adea1
|
230
|
|
Composite MRI measures and short-term disability in patients with clinically isolated syndrome suggestive of MS, file e268c4cb-6190-a6b7-e053-3a05fe0adea1
|
196
|
|
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis, file e268c4c7-68d3-a6b7-e053-3a05fe0adea1
|
165
|
|
Dramatic rebounds of MS during pregnancy following fingolimod withdrawal., file e268c4c8-5f20-a6b7-e053-3a05fe0adea1
|
128
|
|
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis, file e268c4c7-91f3-a6b7-e053-3a05fe0adea1
|
122
|
|
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration, file e268c4c8-5e2b-a6b7-e053-3a05fe0adea1
|
120
|
|
Sirt6 regulates dendritic cell differentiation, maturation, and function, file e268c4c7-989f-a6b7-e053-3a05fe0adea1
|
117
|
|
Cell-based therapeutic strategies for multiple sclerosis., file e268c4c8-584d-a6b7-e053-3a05fe0adea1
|
106
|
|
Ghost spasticity in multiple sclerosis, file e268c4ce-4812-a6b7-e053-3a05fe0adea1
|
106
|
|
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)., file e268c4c8-61ce-a6b7-e053-3a05fe0adea1
|
103
|
|
X-Ray Phase Contrast Tomography Reveals Early Vascular Alterations and Neuronal Loss in a Multiple Sclerosis Model, file e268c4ca-91b3-a6b7-e053-3a05fe0adea1
|
98
|
|
Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS, file e268c4cb-6325-a6b7-e053-3a05fe0adea1
|
88
|
|
Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice, file e268c4cb-34f7-a6b7-e053-3a05fe0adea1
|
80
|
|
Different MRI patterns in MS worsening after stopping fingolimod, file e268c4c9-f569-a6b7-e053-3a05fe0adea1
|
76
|
|
Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure, file e268c4cb-1dff-a6b7-e053-3a05fe0adea1
|
76
|
|
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis, file e268c4c9-bd55-a6b7-e053-3a05fe0adea1
|
75
|
|
The Italian multiple sclerosis register, file e268c4cb-4754-a6b7-e053-3a05fe0adea1
|
72
|
|
Teriflunomide treatment reduces B cells in patients with MS., file e268c4c8-590f-a6b7-e053-3a05fe0adea1
|
69
|
|
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study., file e268c4c6-2da4-a6b7-e053-3a05fe0adea1
|
64
|
|
IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism, file e268c4cb-350b-a6b7-e053-3a05fe0adea1
|
63
|
|
Stem cell transplantation in multiple sclerosis: current status and future prospects., file e268c4c6-20f8-a6b7-e053-3a05fe0adea1
|
53
|
|
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population, file e268c4cc-cc5a-a6b7-e053-3a05fe0adea1
|
40
|
|
Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases, file e268c4c6-0ce0-a6b7-e053-3a05fe0adea1
|
37
|
|
Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks., file e268c4c6-0703-a6b7-e053-3a05fe0adea1
|
35
|
|
Effect of radial shock wave therapy on pain and muscle hypertonia: a double-blind study in patients with multiple sclerosis., file e268c4ce-7ee5-a6b7-e053-3a05fe0adea1
|
35
|
|
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cell, file e268c4cd-8db5-a6b7-e053-3a05fe0adea1
|
34
|
|
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group., file e268c4c6-0701-a6b7-e053-3a05fe0adea1
|
32
|
|
IFN-γ orchestrates mesenchymal stem cell plasticity through the signal transducer and activator of transcription 1 and 3 and mammalian target of rapamycin pathways, file e268c4c7-90a7-a6b7-e053-3a05fe0adea1
|
31
|
|
Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus., file e268c4c7-963f-a6b7-e053-3a05fe0adea1
|
30
|
|
Immunoregulatory functions of mesenchimal stem cells, file e268c4c7-91b7-a6b7-e053-3a05fe0adea1
|
28
|
|
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy., file e268c4c6-0713-a6b7-e053-3a05fe0adea1
|
25
|
|
The immunomodulatory function of mesenchymal stem cells: mode of action and pathways, file e268c4c7-98ca-a6b7-e053-3a05fe0adea1
|
25
|
|
Neuroprotective Potential of Dendritic Cells and Sirtuins in Multiple Sclerosis, file e268c4ce-e459-a6b7-e053-3a05fe0adea1
|
24
|
|
Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS., file e268c4c6-0774-a6b7-e053-3a05fe0adea1
|
23
|
|
Mesenchymal stem cells: a new strategy for immunosuppression?, file e268c4c7-98cc-a6b7-e053-3a05fe0adea1
|
23
|
|
Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis., file e268c4c6-070d-a6b7-e053-3a05fe0adea1
|
22
|
|
Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells., file e268c4c6-0706-a6b7-e053-3a05fe0adea1
|
21
|
|
Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1, file e268c4c6-1edd-a6b7-e053-3a05fe0adea1
|
21
|
|
Immunotherapy for neurological diseases., file e268c4c6-0709-a6b7-e053-3a05fe0adea1
|
18
|
|
Immunological patterns identifying disease course and evolution in multiple sclerosis patients., file e268c4c6-0712-a6b7-e053-3a05fe0adea1
|
17
|
|
Restricted immune responses lead to CNS demyelination and axonal damage., file e268c4c7-9905-a6b7-e053-3a05fe0adea1
|
17
|
|
B-cell differentiation in the CNS of patients with multiple sclerosis., file e268c4c7-a041-a6b7-e053-3a05fe0adea1
|
17
|
|
Costs and quality of life of multiple sclerosis in Italy., file e268c4c6-0ce5-a6b7-e053-3a05fe0adea1
|
16
|
|
Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation., file e268c4c6-16ef-a6b7-e053-3a05fe0adea1
|
16
|
|
Intravenous mesenchymal stem cells administration induces survival and symptom amelioration in mutant SOD1 G93A mice, file e268c4c8-b239-a6b7-e053-3a05fe0adea1
|
16
|
|
Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis., file e268c4c7-9907-a6b7-e053-3a05fe0adea1
|
15
|
|
Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis., file e268c4c6-0716-a6b7-e053-3a05fe0adea1
|
14
|
|
Mesenchymal stem cells exert a remarkable regenerative effect requiring minimal CNS integration: commentary on: "Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function" by Voulgari-Kokota et al., file e268c4c6-16f1-a6b7-e053-3a05fe0adea1
|
14
|
|
Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study, file e268c4c7-9fc2-a6b7-e053-3a05fe0adea1
|
13
|
|
Intravenous mesenchymal stem cells administration induces survival and symptom amelioration in mutant SOD1 G93A mice, file e268c4c8-b1d5-a6b7-e053-3a05fe0adea1
|
13
|
|
Exploring Alzheimer's disease mouse brain through X-ray phase contrast tomography: From the cell to the organ, file e268c4cc-b22a-a6b7-e053-3a05fe0adea1
|
13
|
|
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study, file e268c4cc-0cda-a6b7-e053-3a05fe0adea1
|
12
|
|
Characterization of mouse spinal cord vascular network by means of synchrotron radiation X-ray phase contrast tomography, file e268c4c7-9193-a6b7-e053-3a05fe0adea1
|
11
|
|
Characterization of the response to myelin basic protein in a non human primate model for multiple sclerosis., file e268c4c6-0776-a6b7-e053-3a05fe0adea1
|
10
|
|
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification., file e268c4c6-232b-a6b7-e053-3a05fe0adea1
|
10
|
|
Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis., file e268c4c7-98d1-a6b7-e053-3a05fe0adea1
|
10
|
|
Economic evaluation of treating clinically isolated syndrome and subsequent multiple sclerosis with interferon beta-1b., file e268c4c6-0705-a6b7-e053-3a05fe0adea1
|
9
|
|
Mesenchymal stromal cells and immunity:Introductory overview., file e268c4c7-98c9-a6b7-e053-3a05fe0adea1
|
9
|
|
Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation, file e268c4cd-919d-a6b7-e053-3a05fe0adea1
|
9
|
|
Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection., file e268c4c7-9fc3-a6b7-e053-3a05fe0adea1
|
8
|
|
Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study., file e268c4c6-0708-a6b7-e053-3a05fe0adea1
|
7
|
|
Relapses after treatment with rituximab in a patient with multiple sclerosis and anti myelin-associated glycoprotein polyneuropathy., file e268c4c6-070b-a6b7-e053-3a05fe0adea1
|
7
|
|
Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis., file e268c4c6-1ede-a6b7-e053-3a05fe0adea1
|
7
|
|
Demyelination and axonal damage in a non-human primate model of multiple sclerosis., file e268c4c7-9dff-a6b7-e053-3a05fe0adea1
|
7
|
|
Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57BL/6 mice., file e268c4c7-a042-a6b7-e053-3a05fe0adea1
|
7
|
|
Assessing upper limb function in Multiple Sclerosis by an engineered glove, file e268c4cc-cc58-a6b7-e053-3a05fe0adea1
|
7
|
|
Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration, file e268c4cc-e505-a6b7-e053-3a05fe0adea1
|
7
|
|
Anti-Glutamic Acid Decarboxylase Limbic Encephalitis Without Epilepsy Evolving Into Dementia With Cerebellar Ataxia, file e268c4c6-0663-a6b7-e053-3a05fe0adea1
|
6
|
|
Myelin basic protein intramolecular spreading without disease progression in a patient with multiple sclerosis., file e268c4c6-0777-a6b7-e053-3a05fe0adea1
|
6
|
|
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis., file e268c4c6-0ce6-a6b7-e053-3a05fe0adea1
|
6
|
|
Investigation of paroxysmal dystonia in a patient with multiple sclerosis: a transcranial magnetic stimulation study., file e268c4c6-11b8-a6b7-e053-3a05fe0adea1
|
6
|
|
Adult stem cells for spinal cord injury: what types and how do they work?, file e268c4c6-0707-a6b7-e053-3a05fe0adea1
|
5
|
|
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis., file e268c4c6-0711-a6b7-e053-3a05fe0adea1
|
5
|
|
Guillain Barrè syndrome after reactivation of Herpes Zoster (letter), file e268c4c7-98cf-a6b7-e053-3a05fe0adea1
|
5
|
|
The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction, file e268c4c7-9f80-a6b7-e053-3a05fe0adea1
|
5
|
|
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis., file e268c4c8-b780-a6b7-e053-3a05fe0adea1
|
5
|
|
Pediatric optic neuritis and anti MOG antibodies: a cohort of Italian patients, file e268c4cb-eaff-a6b7-e053-3a05fe0adea1
|
5
|
|
An Early Increase of Blood Leukocyte Subsets in Aneurysmal Subarachnoid Hemorrhage Is Predictive of Vasospasm, file e268c4cd-98a8-a6b7-e053-3a05fe0adea1
|
5
|
|
Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS, file 3965d2c2-4fec-4778-ad79-622f3580c88e
|
4
|
|
C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE., file e268c4c6-0704-a6b7-e053-3a05fe0adea1
|
4
|
|
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis., file e268c4c6-0715-a6b7-e053-3a05fe0adea1
|
4
|
|
Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis., file e268c4c6-08f1-a6b7-e053-3a05fe0adea1
|
4
|
|
Autologous stem cell transplantation for severe autoimmune diseases: a 10-year experience., file e268c4c6-1410-a6b7-e053-3a05fe0adea1
|
4
|
|
A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients., file e268c4c6-f6bb-a6b7-e053-3a05fe0adea1
|
4
|
|
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy, file e268c4c7-29b4-a6b7-e053-3a05fe0adea1
|
4
|
|
Cingulum bundle alterations underlie subjective fatigue in multiple sclerosis, file e268c4c7-83e9-a6b7-e053-3a05fe0adea1
|
4
|
|
Epstein-Barr-negative MS: a true phenomenon?, file e268c4c7-9d81-a6b7-e053-3a05fe0adea1
|
4
|
|
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis., file e268c4c8-af79-a6b7-e053-3a05fe0adea1
|
4
|
|
Aging with multiple sclerosis: Clinical characterization of an elderly population, a cross-sectional study, file 08e4ab46-3c4b-4281-9e41-46db7c1037f6
|
3
|
|
Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application., file e268c4c6-070a-a6b7-e053-3a05fe0adea1
|
3
|
|
Differential display analysis of murine encephalitogenic mRNA., file e268c4c6-0779-a6b7-e053-3a05fe0adea1
|
3
|
|
Acute desipramine restores presynaptic cortical defects in murine experimental autoimmune encephalomyelitis by suppressing central CCL5 overproduction., file e268c4c6-16ed-a6b7-e053-3a05fe0adea1
|
3
|
|
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis., file e268c4c6-16ee-a6b7-e053-3a05fe0adea1
|
3
|
|
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients., file e268c4c6-1a2e-a6b7-e053-3a05fe0adea1
|
3
|
|
NG2, a common
denominator for neuroinflammation, blood-brain barrier alteration, and
oligodendrocyte precursor response in EAE, plays a role in dendritic cell
activation, file e268c4c7-9002-a6b7-e053-3a05fe0adea1
|
3
|
|
Two years follow up of domain specific cognitive training in relapsing remitting multiple sclerosis: A randomized clinical trial, file e268c4c7-91b2-a6b7-e053-3a05fe0adea1
|
3
|
|
Quantitative 3D investigation of Neuronal network in mouse spinal cord model, file e268c4c7-9396-a6b7-e053-3a05fe0adea1
|
3
|
|
Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2
and Myeloid-Dependent Mechanism, file e268c4c7-95d1-a6b7-e053-3a05fe0adea1
|
3
|
|
Human mesenchymal stem cells target adhesion molecules and receptors involved in T cell extravasation, file e268c4c7-9a52-a6b7-e053-3a05fe0adea1
|
3
|
|
Effectiveness of Time Domain and Spectral Domain Optical Coherence Tomograph to Evaluate Eyes with And Without Optic Neuritis in Multiple Sclerosi Patients, file e268c4c8-2941-a6b7-e053-3a05fe0adea1
|
3
|
| Totale |
3.164 |